Analyst Ratings for Avanos Medical (AVNS)

AVNS Rating Summary

AVNS Price Target Summary

* Over Last 12-Mos
  |   Expand Research on AVNS
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: $45.50 (+14%) * Over Last 12-Mos
Rating Score: 0 / 10   Percentile Rank: 0%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/13/2020 Barclays Kristen Stewart Upgrade Equalweight
(Underweight)
30.00
(32.00)
26.40
(39.91)
51.17% Details
11/6/2019 Raymond James Lawrence Keusch Downgrade Market Perform
(Outperform)
N/A
(N/A)
37.08
(39.91)
7.63% Details
Like AVNS Ratings? Also take a look at EFC, FLIR, AEGN, NSA

AVNS Ratings News